EMSella Incontinence Treatment

EMSELLA is a breakthrough FDA cleared treatment for incontinence. This unique technology revolutionizes the women's intimate health and wellness category by providing those suffering from incontinence with a completely non-invasive option. Pelvic floor muscles are the layer of muscles that support the pelvic organs and span the bottom of the pelvis. Strong pelvic floor muscles gives you control over your bladder and bowel. Weakened pelvic floor muscles mean your internal organs are not fully supported and you may have difficulty controlling the release of urine. 

Utilizing electromagnetic stimulation to rehabilitate weakened pelvic muscles and restore neuromuscular control, this treatment aims to address urinary incontinence in both men and women. In addition to the temporary increase of local circulation, individuals may also experience heightened sensitivity during intercourse.

• Stress urinary incontinence. Urine leakage during coughing and sneezing or physical activity. Mainly postpartum women.
• Urge urinary incontinence. Urine leakage, drain strong, sudden need to urinate. Affects all ages.
• Mixed urinary incontinence. Combination of stress and urge urinary incontinence. Mainly post menopausal women.

EMSELLA utilizes electromagnetic energy to deliver thousands of supramaximal pelvic floor muscle contractions in a single 30 minute session. These contractions re-educate the muscles of incontinent patients. The patient remains fully clothed - an easy walk in/walk out procedure. Recommend 6 sessions, twice a week with a followup in 6 months.

Pelvic floor muscles exercises benefits:

• Improve bladder and bowel control
• Reduce the risk of prolapse 
• Improve recovery from childbirth and gynecological surgery (in women)
• Improve recovery after prostate surgery (in men)
• Increase sexual sensation and orgasmic potential
• Increase social confidence and quality of life

You may observe improvement after a single session. The results will typically continue to improve over the next few weeks. To date 5 clinical studies have been published on EMSELLA Studies confirm 95% of patients report an improved quality of life, 86% of patients report less leakage and lower frequency to go, and 75% Pad Reduction.